|
Volumn 29, Issue SUPPL. 6, 2009, Pages
|
Combination angiostatic therapies: Current status
e
NONE
(United States)
|
Author keywords
Intraocular combination therapy; Physiochemical interaction; Retina disease
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
DEXAMETHASONE;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
METALLOPROTEINASE INHIBITOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
SORAFENIB;
SUNITINIB;
TRIAMCINOLONE ACETONIDE;
VANCOMYCIN;
VASCULAR ENDOTHELIAL GROWTH INHIBITOR;
CATARACT;
CELL FUNCTION;
DRUG ACTIVITY;
DRUG ADMINISTRATION ROUTE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
ENDOPHTHALMITIS;
EYE DISEASE;
GLAUCOMA;
HUMAN;
MAMMAL;
NOTE;
PHOTODYNAMIC THERAPY;
RETINA CELL;
RETINA INJURY;
RETINA MACULA AGE RELATED DEGENERATION;
AGED;
ANGIOGENESIS INHIBITORS;
CHOROIDAL NEOVASCULARIZATION;
DRUG THERAPY, COMBINATION;
HUMANS;
INJECTIONS;
MACULAR DEGENERATION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VITREOUS BODY;
|
EID: 68049123135
PISSN: 0275004X
EISSN: None
Source Type: Journal
DOI: 10.1097/IAE.0b013e3181ad22fa Document Type: Note |
Times cited : (3)
|
References (4)
|